Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BD-CAEL: Abilify Maintena + CAE in Bipolar Disorder
NCT03408873Phase 4Completed
- Start
- Apr 2018
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aripiprazole in bipolar disorder (BD). Started Apr 2018; status: completed.
02
Drugs
aripiprazole
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT03408873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03408873.